
AZ1729 is a novel direct, positive allosteric modulator of fatty acid рецептор FFA2 (pEC50=6.9), selectively activates Gi signaling but lacks the capacity to activate FFA2 Gq/G11-mediated signaling pathways.
AZ1729 is a novel direct, positive allosteric modulator of fatty acid receptor FFA2 (pEC50=6.9), selectively activates Gi signaling but lacks the capacity to activate FFA2 Gq/G11-mediated signaling pathways.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.